213 related articles for article (PubMed ID: 19948766)
1. Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.
Ge Q; Dallas A; Ilves H; Shorenstein J; Behlke MA; Johnston BH
RNA; 2010 Jan; 16(1):118-30. PubMed ID: 19948766
[TBL] [Abstract][Full Text] [Related]
2. Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity.
Ge Q; Ilves H; Dallas A; Kumar P; Shorenstein J; Kazakov SA; Johnston BH
RNA; 2010 Jan; 16(1):106-17. PubMed ID: 19952116
[TBL] [Abstract][Full Text] [Related]
3. Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing.
Dallas A; Ilves H; Ge Q; Kumar P; Shorenstein J; Kazakov SA; Cuellar TL; McManus MT; Behlke MA; Johnston BH
Nucleic Acids Res; 2012 Oct; 40(18):9255-71. PubMed ID: 22810205
[TBL] [Abstract][Full Text] [Related]
4. Design and chemical modification of synthetic short shRNAs as potent RNAi triggers.
Dallas A; Johnston BH
Methods Mol Biol; 2013; 942():279-90. PubMed ID: 23027057
[TBL] [Abstract][Full Text] [Related]
5. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
[TBL] [Abstract][Full Text] [Related]
6. An artificial cationic oligosaccharide combined with phosphorothioate linkages strongly improves siRNA stability.
Irie A; Sato K; Hara RI; Wada T; Shibasaki F
Sci Rep; 2020 Sep; 10(1):14845. PubMed ID: 32908235
[TBL] [Abstract][Full Text] [Related]
7. Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs.
Kotikam V; Rozners E
Acc Chem Res; 2020 Sep; 53(9):1782-1790. PubMed ID: 32658452
[TBL] [Abstract][Full Text] [Related]
8. Chemical modification of siRNAs to improve serum stability without loss of efficacy.
Choung S; Kim YJ; Kim S; Park HO; Choi YC
Biochem Biophys Res Commun; 2006 Apr; 342(3):919-27. PubMed ID: 16598842
[TBL] [Abstract][Full Text] [Related]
9. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
[TBL] [Abstract][Full Text] [Related]
10. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
Czauderna F; Fechtner M; Dames S; Aygün H; Klippel A; Pronk GJ; Giese K; Kaufmann J
Nucleic Acids Res; 2003 Jun; 31(11):2705-16. PubMed ID: 12771196
[TBL] [Abstract][Full Text] [Related]
11. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
12. Effects of conformational alteration induced by D-/L-isonucleoside incorporation in siRNA on their stability in serum and silencing activity.
Huang Y; Chen Z; Chen Y; Zhang H; Zhang Y; Zhao Y; Yang Z; Zhang L
Bioconjug Chem; 2013 Jun; 24(6):951-9. PubMed ID: 23682837
[TBL] [Abstract][Full Text] [Related]
13. Modulation of thermal stability can enhance the potency of siRNA.
Addepalli H; Meena ; Peng CG; Wang G; Fan Y; Charisse K; Jayaprakash KN; Rajeev KG; Pandey RK; Lavine G; Zhang L; Jahn-Hofmann K; Hadwiger P; Manoharan M; Maier MA
Nucleic Acids Res; 2010 Nov; 38(20):7320-31. PubMed ID: 20610434
[TBL] [Abstract][Full Text] [Related]
14. Optimization of duplex stability and terminal asymmetry for shRNA design.
Matveeva OV; Kang Y; Spiridonov AN; Saetrom P; Nemtsov VA; Ogurtsov AY; Nechipurenko YD; Shabalina SA
PLoS One; 2010 Apr; 5(4):e10180. PubMed ID: 20422034
[TBL] [Abstract][Full Text] [Related]
15. RNA major groove modifications improve siRNA stability and biological activity.
Terrazas M; Kool ET
Nucleic Acids Res; 2009 Feb; 37(2):346-53. PubMed ID: 19042976
[TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory properties and antiviral activity of modified HBV-specific siRNAs.
Shin D; Kim SI; Park M; Kim M
Biochem Biophys Res Commun; 2007 Dec; 364(3):436-42. PubMed ID: 17963721
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.
Jurk M; Chikh G; Schulte B; Kritzler A; Richardt-Pargmann D; Lampron C; Luu R; Krieg AM; Vicari AP; Vollmer J
Nucleic Acid Ther; 2011 Jun; 21(3):201-14. PubMed ID: 21749297
[TBL] [Abstract][Full Text] [Related]
18. Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
Sano M; Sierant M; Miyagishi M; Nakanishi M; Takagi Y; Sutou S
Nucleic Acids Res; 2008 Oct; 36(18):5812-21. PubMed ID: 18782830
[TBL] [Abstract][Full Text] [Related]
19. Chemical modification of siRNAs for in vivo use.
Behlke MA
Oligonucleotides; 2008 Dec; 18(4):305-19. PubMed ID: 19025401
[TBL] [Abstract][Full Text] [Related]
20. RNA interference using boranophosphate siRNAs: structure-activity relationships.
Hall AH; Wan J; Shaughnessy EE; Ramsay Shaw B; Alexander KA
Nucleic Acids Res; 2004; 32(20):5991-6000. PubMed ID: 15545637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
